Protalix BioTherapeutics, Inc. - COM (PLX)

Historical Holders from Q4 2019 to Q3 2025

Symbol
PLX on NYSE
CUSIP
74365A309
Type / Class
Equity / COM
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
13.9M
Holdings value
$30.9M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
75
Number of buys
32
Number of sells
-24
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Protalix BioTherapeutics, Inc. - COM (PLX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 13.9M $30.9M +$4.62M $2.22 75
2025 Q2 11.9M $17.6M +$1.91M $1.48 62
2025 Q1 8.19M $21M +$9.62M $2.56 63
2024 Q4 4.47M $8.4M +$2.2M $1.88 46
2024 Q3 3.38M $3.45M -$2.25M $1.02 43
2024 Q2 5.63M $6.58M -$4.72M $1.17 64
2024 Q1 9.45M $11.9M -$696K $1.26 61
2023 Q4 9.85M $17.5M +$1.24M $1.78 66
2023 Q3 9.17M $15.2M -$98.2K $1.66 61
2023 Q2 8.97M $17.9M +$12M $2.00 66
2023 Q1 2.94M $6.15M +$448K $2.10 34
2022 Q4 3.57M $4.87M +$112K $1.37 27
2022 Q3 3.55M $3.7M +$2.4M $1.04 25
2022 Q2 1.19M $1.3M +$26.6K $1.09 28
2022 Q1 1.22M $1.29M -$1.77M $1.06 28
2021 Q4 2.92M $2.44M -$1.65M $0.83 24
2021 Q3 4.41M $5.91M +$92.8K $1.33 31
2021 Q2 4.31M $8.24M -$19.3M $1.91 30
2021 Q1 8.82M $39.3M +$21.2M $4.46 35
2020 Q4 4.09M $14.8M -$3.21M $3.63 22
2020 Q3 4.76M $18.4M -$1.93M $3.87 25
2020 Q2 5.26M $19.8M -$2.82M $3.79 26
2020 Q1 6M $14.1M +$12.6M $2.35 15
2019 Q4 644K $2.11M +$2.11M $3.28 7